BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34530148)

  • 1. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
    De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
    World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
    Hofstetter CP; Hofer AS; Levi AD
    J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Lumbar Fusion Rates With and Without the Use of rhBMP-2.
    Galimberti F; Lubelski D; Healy AT; Wang T; Abdullah KG; Nowacki AS; Benzel EC; Mroz TE
    Spine (Phila Pa 1976); 2015 Jul; 40(14):1132-9. PubMed ID: 25955186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
    Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
    Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
    Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
    J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
    Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
    Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
    McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
    J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
    Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
    J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
    Lu DC; Tumialán LM; Chou D
    J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
    J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres.
    Vincentelli AF; Szadkowski M; Vardon D; Litrico S; Fuentès S; Steib JP; Le Huec JC; Huppert J; Dubois G; Lenoir T; Sailhan F; Passuti N
    Orthop Traumatol Surg Res; 2019 Oct; 105(6):1157-1163. PubMed ID: 31324520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.